Healthcare Realty Trust Incorporated
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.18B | $1.27B | $1.34B | $932.6M | $534.8M | $499.6M | $692.0M | $696.4M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $72.6M | $83.1M | $58.4M | $52.7M | $34.2M | $30.7M | $41.4M | $35.2M |
| Operating Income | — | — | — | — | $-171.7M | $-169.6M | $49.8M | $49.2M |
| Operating Margin | — | — | — | — | -32.1% | -33.9% | 7.2% | 7.1% |
| Interest Expense | — | — | $258.6M | $146.7M | $53.1M | $56.2M | $96.6M | $101.8M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-246.1M | $-654.5M | $-278.3M | $40.9M | $66.7M | $72.2M | $30.2M | $213.5M |
| Net Margin | -20.8% | -51.6% | -20.7% | 4.4% | 12.5% | 14.4% | 4.4% | 30.7% |
| EPS (Basic) | $-0.71 | $-1.81 | $-0.74 | $0.15 | $0.45 | $0.52 | $0.15 | $1.04 |
| EPS (Diluted) | $-0.71 | $-1.81 | $-0.74 | $0.15 | $0.45 | $0.52 | $0.14 | $1.02 |
| Shares Outstanding (Basic) | 349.8M | 365.6M | 378.9M | 252.4M | 142.6M | 133.9M | 205.7M | 206.1M |
| Shares Outstanding (Diluted) | 349.8M | 365.6M | 378.9M | 253.9M | 142.7M | 134.0M | 209.6M | 210.1M |
| Dividends Per Share | $1.10 | $1.24 | $1.24 | $1.24 | $1.21 | $1.20 | $1.25 | $1.23 |